Hennion & Walsh Asset Management Inc. Has $695,000 Holdings in CRISPR Therapeutics AG (NASDAQ:CRSP)

Hennion & Walsh Asset Management Inc. increased its stake in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 89.5% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 15,315 shares of the company’s stock after purchasing an additional 7,235 shares during the period. […]

Leave a Reply

Your email address will not be published.

Previous post Allspring Global Investments Holdings LLC Has $28.65 Million Stock Holdings in Masonite International Co. (NYSE:DOOR)
Next post US spent over $1 billion on Russian uranium – media